問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberEMR62202-505
Not yet recruiting

2008-12-01 - 2012-12-31

Phase II

Terminated6

  • Trial Applicant

    MERCK LTD.

  • Sponsor

  • Trial scale

  • Update

    2026/03/01

Investigators and Locations

Principal Investigator Wu-Chou Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Hwei-Ming Wang Division of Colorectal Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Jen-Jyn Lin Division of Colorectal Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Kun-Huei Yeh Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 許自齊 Division of Colorectal Surgery

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tsai-Sheng Yang Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    36 participants

  • Global

    260 participants